Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H2O.ai provides an end-to-end cloud-based and on-premises artificial intelligence and machine learning platform used by over 20,000 organizations globally. Its technology powers predictive analytics and generative AI solutions across industries including healthcare, financial services, insurance, manufacturing, marketing, retail and telecommunications. In healthcare/life sciences specifically, its tools are used for automating processes in pharma apps and provider/payer operations but it does not itself develop therapeutics or diagnostics. The company has been recognized as a visionary leader in automated machine learning by Gartner Magic Quadrant for several years running. Customers include Fortune 500 companies such as GlaxoSmithKline and strategic partners/investors like Goldman Sachs and NVIDIA. Recent product innovations include h2oGPTe for enterprise-grade generative AI with support for retrieval augmented generation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H2O.ai.